{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:09:50Z","timestamp":1790014190929,"version":"4.0.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2024YFC3505100"],"award-info":[{"award-number":["2024YFC3505100"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dysbiosis of gut microbiota plays a key role in type 1 diabetes mellitus (T1DM). Fecal microbiota transplantation represents a novel therapeutic avenue. We hypothesize that youth-derived fecal microbiota transplantation (yFMT) can remodel the gut microecosystem and improve clinical outcomes. This pilot trial aims to assess the feasibility, safety, and preliminary efficacy of yFMT in adults with T1DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This single-center, randomized, double-blind, placebo-controlled pilot study will enroll adults with T1DM who have suboptimal glycemic outcomes (glycated hemoglobin [HbA1c] of 7.0\u201314.0% or time in range [TIR] &lt;70%). Following a 17-day run-in period for insulin optimization, continuous glucose monitoring (CGM) wearing, baseline assessments and bowel preparation, participants will be randomly allocated (1:1) to take yFMT or placebo capsules for 6 consecutive days, alongside their standard insulin therapy, and then complete a 12-week follow-up. The primary efficacy endpoint is the change from baseline in the rate of achieving the composite target of TIR\u2009&gt;\u200970% and time below range &lt;4% at 12 weeks post-randomization. Secondary efficacy endpoints include: (1) the change from baseline in the same composite achievement rate at 4 weeks post-intervention; (2) changes from baseline at Weeks 4 and 12 in other glycemic metrics (including HbA1c, fasting plasma glucose, 2-hour postprandial glucose, and additional CGM metrics), C-peptide, immune responses, infection markers, and gut microbiota composition; and (3) changes from baseline at Week 12 in serum metabolomic profiles (bile acids, short-chain fatty acids, and other related metabolites). Feasibility will be assessed through recruitment rate, retention rate, intervention adherence, and acceptability. Safety endpoints include the incidence of adverse events and serious adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Our findings will offer new insight into the feasibility and effects of oral yFMT capsules in adults with T1DM and provide the necessary evidence to power a subsequent multicenter large-scale study. Exploratory biomarker analyses conducted within this study may further pave the way for future individualized microbiome\u2011based therapeutics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Chinese Clinical Trial Registry identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/ChiCTR2500111955\" xlink:type=\"simple\">ChiCTR2500111955<\/jats:ext-link>\n                      (November 7, 2025).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0343078","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:23:20Z","timestamp":1790011400000},"page":"e0343078","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy, safety, and feasibility of youth-derived fecal microbiota transplantation among adults with type 1 diabetes mellitus: A protocol of Pilot Randomized Controlled Trial"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9172-4136","authenticated-orcid":true,"given":"Xunuo","family":"Chen","sequence":"first","affiliation":[{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Endocrinology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyun","family":"Lei","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Endocrinology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tang","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Endocrinology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Wang","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Endocrinology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Chen","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Endocrinology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9912-530X","authenticated-orcid":true,"given":"Yanxin","family":"Liu","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Endocrinology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Li","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Endocrinology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Endocrinology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonge","family":"Wang","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Endocrinology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Li","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Clinical Nutrition"]},{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Neurosurgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-0225","authenticated-orcid":true,"given":"Zhe","family":"Dai","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Endocrinology"]},{"name":"Zhongnan Hospital of Wuhan University","place":["Wuhan, China"],"department":["Department of Clinical Nutrition"]},{"name":"State Key Laboratory of Metabolism and Regulation in Complex Organisms, College of Life Sciences, Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"issue":"7","key":"pone.0343078.ref001","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"KG Alberti","year":"1998","journal-title":"Diabet Med"},{"issue":"6","key":"pone.0343078.ref002","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc15-0078","article-title":"Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry","volume":"38","author":"KM Miller","year":"2015","journal-title":"Diabetes Care"},{"issue":"2","key":"pone.0343078.ref003","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018","volume":"21","author":"NC Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"pone.0343078.ref004","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/dmrr.2547","article-title":"Secondary diabetic ketoacidosis and severe hypoglycaemia in patients with established type 1 diabetes mellitus in China: a multicentre registration study","volume":"30","author":"J Li","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"pone.0343078.ref005","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/dmrr.2716","article-title":"Glycaemic control and its associated factors in Chinese adults with type 1 diabetes mellitus","volume":"31","author":"L Liu","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"pone.0343078.ref006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0366-6999.196574","article-title":"Behavioral analysis of Chinese adult patients with type 1 diabetes on self-monitoring of blood glucose","volume":"130","author":"ZY Qin","year":"2017","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"pone.0343078.ref007","first-page":"215","article-title":"A cross-sectional investigation of self-monitoring of blood glucose in adults with type 1 diabetes melitus in Guangdong Province","volume":"8","author":"XY Zheng","year":"2016","journal-title":"Chin J Diabetes"},{"issue":"3","key":"pone.0343078.ref008","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrendo.2015.218","article-title":"The role of the intestinal microbiota in type 1 diabetes mellitus","volume":"12","author":"M Knip","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"pone.0343078.ref009","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00125-014-3274-0","article-title":"Aberrant gut microbiota composition at the onset of type 1 diabetes in young children","volume":"57","author":"MC de Goffau","year":"2014","journal-title":"Diabetologia"},{"issue":"1","key":"pone.0343078.ref010","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1038\/s41467-022-33656-4","article-title":"Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes","volume":"13","author":"X Yuan","year":"2022","journal-title":"Nat Commun"},{"key":"pone.0343078.ref011","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1741-7015-11-46","article-title":"Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study","volume":"11","author":"M Murri","year":"2013","journal-title":"BMC Med"},{"issue":"8","key":"pone.0343078.ref012","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00125-005-1831-2","article-title":"Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse","volume":"48","author":"F Calcinaro","year":"2005","journal-title":"Diabetologia"},{"issue":"8","key":"pone.0343078.ref013","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/gutjnl-2017-314508","article-title":"Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice","volume":"67","author":"A H\u00e4nninen","year":"2018","journal-title":"Gut"},{"issue":"1","key":"pone.0343078.ref014","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2020-322630","article-title":"Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial","volume":"70","author":"P de Groot","year":"2021","journal-title":"Gut"},{"issue":"12","key":"pone.0343078.ref015","first-page":"962","article-title":"Efficacy and safety of washed microbiota transplantation in the treatment of brittle diabetes","volume":"12","author":"YY Li","year":"2020","journal-title":"Chin J Diabetes"},{"issue":"5","key":"pone.0343078.ref016","doi-asserted-by":"crossref","first-page":"102130","DOI":"10.1016\/j.xcrm.2025.102130","article-title":"Restoration of intestinal secondary bile acid synthesis: A potential approach to improve pancreatic \u03b2 cell function in type 1 diabetes","volume":"6","author":"Q Liu","year":"2025","journal-title":"Cell Rep Med"},{"key":"pone.0343078.ref017","doi-asserted-by":"crossref","first-page":"103000","DOI":"10.1016\/j.eclinm.2024.103000","article-title":"Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trial","volume":"79","author":"KL H\u00f8yer","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"9","key":"pone.0343078.ref018","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.cmet.2023.06.010","article-title":"Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes","volume":"35","author":"J Yang","year":"2023","journal-title":"Cell Metab"},{"issue":"7402","key":"pone.0343078.ref019","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"T Yatsunenko","year":"2012","journal-title":"Nature"},{"key":"pone.0343078.ref020","doi-asserted-by":"crossref","first-page":"1412991","DOI":"10.3389\/fmicb.2024.1412991","article-title":"Age over sex: evaluating gut microbiota differences in healthy Chinese populations","volume":"15","author":"J Wu","year":"2024","journal-title":"Front Microbiol"},{"issue":"9","key":"pone.0343078.ref021","first-page":"757","article-title":"Chinese expert consensus on screening and management of fecal microbiota transplantation donors (2022 edition)","volume":"25","author":"Society of Parenteral and Enteral Nutrition, Chinese Medical Association, Microecology Professional Committee of Shanghai Preventive Medicine Association","year":"2022","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"1","key":"pone.0343078.ref022","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12967-024-05832-1","article-title":"Fecal microbiota transplantation restores gut microbiota diversity in children with active Crohn\u2019s disease: a prospective trial","volume":"23","author":"B Zou","year":"2025","journal-title":"J Transl Med"},{"issue":"3","key":"pone.0343078.ref023","first-page":"325","article-title":"Application and reflection on pilot study in acupuncture clinical research","volume":"41","author":"Y Wang","year":"2021","journal-title":"Zhongguo Zhen Jiu"},{"issue":"5","key":"pone.0343078.ref024","doi-asserted-by":"crossref","first-page":"101034","DOI":"10.1016\/j.lanmic.2024.101034","article-title":"Effects of clinical donor characteristics on the success of faecal microbiota transplantation for patients in Denmark with Clostridioides difficile infection: a single-centre, prospective cohort study","volume":"6","author":"A Karmisholt Grosen","year":"2025","journal-title":"Lancet Microbe"},{"issue":"2","key":"pone.0343078.ref025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MPG.0000000000003336","article-title":"Fecal Microbiota Transplantation Commonly Failed in Children With Co-Morbidities","volume":"74","author":"R Kellermayer","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:23:29Z","timestamp":1790011409000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343078"}},"subtitle":[],"editor":[{"given":"Ze","family":"Xiang","sequence":"first","affiliation":[{"name":"Zhejiang University","place":["CHINA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0343078","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}